Targeting death and decoy receptors of the tumour-necrosis factor superfamily

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature Reviews. Cancer

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc821PMID 12189384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The TNF Receptor I-Associated Protein TRADD Signals Cell Death and NF-KB Activation

  2003cited by this paper
• TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

  2002cited by this paper
• Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax

  2002cited by this paper
• TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

  2002cited by this paper
• Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

  2002cited by this paper
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1

  2002cited by this paper
• Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.

  2001cited by this paper
• Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.

  2001cited by this paper
• Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.

  2001cited by this paper
• The effects of limb perfusion with tumor necrosis factor on circulating levels of proinflammatory cytokines.

  2001cited by this paper
• Caspase-10 is an initiator caspase in death receptor signaling

  2001cited by this paper
• Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL

  2001cited by this paper
• Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy

  2001cited by this paper
• Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

  2001cited by this paper
• Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety.

  2001cited by this paper
• Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1

  2001cited by this paper
• SNARE-mediated membrane fusion

  2001cited by this paper
• A Molecular Whodunit

  2001cited by this paper
• The effects of limb perfusion with tumor necrosis factor on circulating levels of proinflammatory cytokines.

  2001cited by this paper
• Till Death Us Do Part

  2001cited by this paper
• Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4

  2001cited by this paper
• TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications.

  2001cited by this paper
• Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β 

  2001cited by this paper
• Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.

  2001cited by this paper
• Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8*

  2001cited by this paper
• Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity.

  2001cited by this paper
• Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells.

  2001cited by this paper
• Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

  2001cited by this paper
• Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma.

  2001cited by this paper
• BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF

  2001cited by this paper
• Avoiding premature apoptosis of normal epidermal cells

  2001cited by this paper
• The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology

  2001cited by this paper
• Apoptosis. Till death us do part.

  2001cited by this paper
• Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

  2001cited by this paper
• Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

  2001cited by this paper
• A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

  2001cited by this paper
• Rel/NF-κB Transcription Factors Protect against Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Up-regulating the TRAIL Decoy Receptor DcR1*

  2001cited by this paper
• Impaired c-Jun Amino Terminal Kinase Activity and T Cell Differentiation in Death Receptor 6–deficient Mice

  2001cited by this paper
• Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

  2001cited by this paper
• Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

  2000cited by this paper
• Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

  2000cited by this paper
• Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane

  2000cited by this paper
• Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

  2000cited by this paper
• TNFα and the TNF receptor superfamily: Structure‐function relationship(s)

  2000cited by this paper
• Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

  2000cited by this paper
• Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.

  2000cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.

  2000cited by this paper
• tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c.

  2000cited by this paper
• Reovirus-Induced Apoptosis Is Mediated by TRAIL

  2000cited by this paper
• Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

  2000cited by this paper
• FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.

  2000cited by this paper
• Apoptotic pathways: paper wraps stone blunts scissors.

  2000cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000cited by this paper
• The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

  2000cited by this paper
• Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.

  2000cited by this paper
• TNF registered in Europe: does TNF get a second chance?

  2000cited by this paper
• Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

  2000cited by this paper
• TRAIL receptor-2 signals apoptosis through FADD and caspase-8

  2000cited by this paper
• Cysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAIL*

  2000cited by this paper
• Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.

  2000cited by this paper
• Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.

  2000cited by this paper
• The Lymphotoxin-β Receptor Is Necessary and Sufficient for LIGHT-mediated Apoptosis of Tumor Cells*

  2000cited by this paper
• The Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors TRAIL-R1 and TRAIL-R2 Have Distinct Cross-linking Requirements for Initiation of Apoptosis and Are Non-redundant in JNK Activation*

  2000cited by this paper
• Temperature-sensitive Differential Affinity of TRAIL for Its Receptors

  2000cited by this paper
• A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL.

  2000cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Type I Interferons (IFNs) Regulate Tumor Necrosis Factor–related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of  Type I IFNs

  1999cited by this paper
• Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.

  1999cited by this paper
• Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death*

  1999cited by this paper
• Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein

  1999cited by this paper
• Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity.

  1999cited by this paper
• TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

  1999cited by this paper
• The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

  1999cited by this paper
• A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis*

  1999cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.

  1999cited by this paper
• Inhibition of Death Receptor Signaling by Flice-Inhibitory Protein as a Mechanism for Immune Escape of Tumors

  1999cited by this paper
• Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

  1999cited by this paper
• Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.

  1999cited by this paper
• Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

  1999cited by this paper
• Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

  1999cited by this paper
• Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells*

  1999cited by this paper
• Apoptosis control by death and decoy receptors.

  1999cited by this paper
• Tumor necrosis factor receptor and Fas signaling mechanisms.

  1999cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

  1998cited by this paper
• Surface expression of TRAIL/Apo‐2 ligand in activated mouse T and B cells

  1998cited by this paper
• TRAIL/Apo‐2‐ligand‐induced apoptosis in human T cells

  1998cited by this paper
• Involvement of APO2 ligand/TRAIL in activation‐induced death of Jurkat and human peripheral blood T cells

  1998cited by this paper
• A matter of life and cell death.

  1998cited by this paper
• APO2 ligand: a novel lethal weapon against malignant glioma?

  1998cited by this paper
• Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.

  1998cited by this paper
• Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage

  1998cited by this paper
• Identification and functional characterization of DR6, a novel death domain‐containing TNF receptor

  1998cited by this paper
• Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.

  1998cited by this paper

• [cGAS-STING agonist cGAMP enhances natural killer cell-mediated cytotoxicity against gastric cancer cells].

  2026cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter

  2025cites this paper
• Detrimental effects of advanced glycation end-products (AGEs) on a 3D skeletal muscle model in microphysiological system.

  2025cites this paper
• Molecular mechanisms of programmed cell death and potential targeted pharmacotherapy in ischemic stroke (Review)

  2025cites this paper
• Identification of radiation-sensitive genes as biomarkers for biodosimetry: an ex vivo analysis of TNFRSF10B, ZMAT3, POLH, and PLK2 in human blood samples

  2025cites this paper
• Dissecting regulated cell death states and transformation mechanisms in the evolutionary trajectory of 30 cancers

  2025cites this paper
• Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy

  2025cites this paper
• Comparative Assessment of Various Formats of TRAIL in Three-Dimensional Cell Culture and Patient-Derived Tumoroids of Colorectal Cancer.

  2025cites this paper
• Current approaches overcome the limit of TRAIL-based treatment in colorectal cancer: From fusion protein to nano-delivery platform.

  2025cites this paper
• Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors

  2025cites this paper
• Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics.

  2024cites this paper
• Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins

  2024cites this paper
• Coexpression of TP53, BIM, and PTEN Enhances the Therapeutic Efficacy of Non-Small-Cell Lung Cancer.

  2024cites this paper
• Tsyn-seq: a T cell synapse-based antigen identification platform.

  2024cites this paper
• Zosterabisphenone B, a new diarylheptanoid heterodimer from the seagrass Zostera marina, induces apoptosis cell death in colon cancer cells and reduces tumour growth in mice

  2024cites this paper
• Targeted Cancer Stem Cell Therapeutics: An Update.

  2024cites this paper
• A decoy receptor derived from alternative splicing fine-tunes cytokinin signaling in Arabidopsis.

  2024cites this paper
• Exploring innovative curcumin-loaded hydrogels: Novel approaches to combat antimicrobial resistance

  2024cites this paper
• Design and synthesis of DNA origami nanostructures to control TNF receptor activation

  2024cites this paper
• Apoptosis of Pancreatic Cancer Cells after Co-Treatment with Eugenol and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

  2024cites this paper
• DNA nanoswitches pack an anti-cancer punch

  2024cites this paper
• Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis.

  2024cites this paper
• A DNA robotic switch with regulated autonomous display of cytotoxic ligand nanopatterns

  2024cites this paper
• NIR-II Light-Actuated Nanomotors for Enhanced Photoimmunotherapy Toward Hepatocellular Carcinoma.

  2024cites this paper
• Cellular Senescence and Anti-Aging Strategies in Aesthetic Medicine: A Bibliometric Analysis and Brief Review

  2024cites this paper
• Chemical synthetic approaches to mimic the TRAIL: promising cancer therapeutics.

  2024cites this paper
• Nanomaterials-induced programmed cell death: Focus on mitochondria.

  2024cites this paper
• Small molecule targeted therapies for endometrial cancer: progress, challenges, and opportunities.

  2024cites this paper
• Tetrandrine for Targeting Therapy Resistance in Cancer.

  2024cites this paper
• Inflammation as a driver of hematological malignancies

  2024cites this paper
• Mechanisms of Biological Effects of Ionic Liquids: From Single Cells to Multicellular Organisms.

  2024cites this paper
• Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication

  2024cites this paper
• Potential of dehydroepiandrosterone and quercetin to ameliorate copper oxide nanoparticles induced hepatotoxicity in albino wistar rats

  2024cites this paper
• Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma.

  2024cites this paper
• Diversity and complexity of cell death: a historical review

  2023cites this paper
• Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study

  2023cites this paper
• Anti-Cancer Effect of Neural Stem Cells Transfected with Carboxylesterase and sTRAIL Genes in Animals with Brain Lesions of Lung Cancer

  2023cites this paper
• Integration of functional peptides into nucleic acid-based nanostructures.

  2023cites this paper
• Effects and mechanism of small molecule additives on recombinant protein in CHO cells

  2023cites this paper
• Consequences of Glucose Enriched Diet on Oncologic Patients

  2023cites this paper
• Anti-apoptosis effect of traditional Chinese medicine in the treatment of cerebral ischemia–reperfusion injury

  2023cites this paper
• Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis.

  2023cites this paper
• γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

  2023cites this paper
• The mechanism of chronic intracellular infection with Brucella spp.

  2023cites this paper
• Cortisol Sensitizes Cochlear Hair Cells to Gentamicin Ototoxicity Via Endogenous Apoptotic Pathway

  2023cites this paper
• Santin (5,7-Dihydroxy-3,6,4′-Trimetoxy-Flavone) Enhances TRAIL-Mediated Apoptosis in Colon Cancer Cells

  2023cites this paper
• Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.

  2022cites this paper
• Therapeutics targeting BCL2 family proteins

  2022cites this paper
• Molecular mechanisms of cell death

  2022cites this paper
• A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling

  2022cites this paper
• Folic acid-loaded chitosan nanoparticles: Cytotoxicity, acute and sub-acute oral toxicity and bioavailability in Wistar rats

  2022cites this paper
• Evaluation of novel CDK-inhibitors in combination with apoptosis-modulating agents for the treatment of colorectal cancer

  2022cites this paper
• TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems

  2022cites this paper
• Dietary Supplementation with Epicatechin Improves Intestinal Barrier Integrity in Mice

  2022cites this paper
• Bioymifi suppresses Burkitt’s lymphoma cell line proliferation via cell cycle arrest and apoptosis

  2022cites this paper
• A review: Systematic research approach on toxicity model of liver and kidney in laboratory animals

  2022cites this paper
• The Resveratrol Oligomers Cis- and Trans-gnetin H Inhibit Human Cancer Cells by Induction of Apoptosis and Oxidative Stress

  2022cites this paper
• University of Groningen Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model Duiker,

  2022cites this paper
• Free Fatty Acids Induce Lipid Accumulation, Autophagy, and Apoptosis in Human Sebocytes

  2022cites this paper
• Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC).

  2022influential citation
• T Lymphocyte-Derived Exosomes and Their Applications in Cancer Therapy

  2022cites this paper
• A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling

  2022cites this paper
• Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy

  2022cites this paper
• Spatiotemporally light controlled “drug-free” macromolecules via upconversion-nanoparticle for precise tumor therapy

  2022cites this paper
• Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis

  2022cites this paper
• Protective Effects of Natural Polysaccharides on Intestinal Barrier Injury: A Review.

  2022cites this paper
• Soluble forms of cytokine and growth factor receptors: mechanisms of generation and modes of action in the regulation of local and systemic inflammation

  2022cites this paper
• Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development

  2022cites this paper
• Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy.

  2022cites this paper
• Effects of trichostatin A on the intrinsic and extrinsic apoptotic pathway, cell viability, and apoptosis induction in hepatocellular carcinoma cell lines

  2021cites this paper
• TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma.

  2021cites this paper
• Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies

  2021influential citation
• Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis

  2021cites this paper
• TRAIL Conjugated Silver Nanoparticle Synthesis, Characterization and Therapeutic Effects on HT-29 Colon Cancer Cells

  2021cites this paper
• Modulation of Apoptosis Pathways in the Biology and Treatment of Multiple Myeloma

  2021cites this paper
• Aquaporin 4 and brain-related disorders: Insights into its apoptosis roles

  2021cites this paper
• Functional characterization of a putative Tumor Necrosis Factor Superfamily Member 10 in blood clam (Tegillarca granosa).

  2021cites this paper
• Inhibitory Effect of Lentivirus-Mediated Gag-Caspase-8 on the Growth of HER-2 Overexpressing Primary Human Breast Cancer Cells

  2021cites this paper
• The genetic landscape of the FAS pathway deficiencies

  2021cites this paper
• RETRACTED ARTICLE: Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway

  2021cites this paper
• Oncogenic viruses and chemoresistance: What do we know?

  2021cites this paper
• Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy.

  2021cites this paper
• Oridonin induces autophagy-mediated cell death in pancreatic cancer by activating the c-Jun N-terminal kinase pathway and inhibiting phosphoinositide 3-kinase signaling

  2021cites this paper
• Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models

  2021cites this paper
• Branched I antigen regulated cell susceptibility against natural killer cytotoxicity through its N-linked glycosylation and overall expression.

  2021cites this paper
• Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T‐cells and tumour cells

  2021cites this paper
• Apoptotic Pathway

  2021cites this paper
• Potential of miRNAs in cervical cancer chemoresistance

  2021cites this paper
• Structural insights of macromolecules involved in bacteria-induced apoptosis in the pathogenesis of human diseases.

  2021cites this paper
• Regulation of Biological Functions at the Cell Interface by DNA Nanostructures

  2021cites this paper
• Low-Molecular-Weight Chitosan Attenuates Lipopolysaccharide-Induced Inflammation in IPEC-J2 Cells by Inhibiting the Nuclear Factor-κB Signalling Pathway

  2021cites this paper
• The role of Se content in improving anti-tumor activities and its potential mechanism for selenized Artemisia sphaerocephala polysaccharides.

  2021cites this paper
• Using the Zebrafish Lateral Line to Understand the Roles of Mitochondria in Sensorineural Hearing Loss

  2021cites this paper
• Spatially targeting of tumor-associated macrophages and cancer cells for suppression of spontaneously metastatic tumor

  2021cites this paper
• Effects of hypoxia on the mRNA expressions of TRAIL-mediated cell death related genes in hypoxia-tolerant rodent (Nannospalax nehringi) and some characteristics of these proteins

  2021cites this paper
• Decoy Receptor 3 Promotes Preosteoclast Cell Death via Reactive Oxygen Species-Induced Fas Ligand Expression and the IL-1α/IL-1 Receptor Antagonist Pathway

  2020cites this paper
• Amelioration of oxidative stress-mediated apoptosis in copper oxide nanoparticles-induced liver injury in rats by potent antioxidants

  2020cites this paper
• Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model.

  2020cites this paper
• Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system

  2020cites this paper